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cally active protein of about 111 kDa and an active fragment 
of about 59 kDa. Methods for inhibiting PARG expression 
or overexpressing PARG in a subject for therapeutic bene?t 
are described. Exemplary of PARG inhibitors are anti-sense 
oligonucleotides. The invention has implications for treat 
ment of neoplastic disorder, heart attack, stroke, and neu 
rodegenerative diseases. Methods for detecting a mutant 
PARG allele are also described. Antibodies immunoreactive 
With PARGs and fragments thereof are described. 
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